Global Self-administered Drugs Market Professional Survey Report 2017

December 2017 | 102 pages | ID: G434DB1EE4BEN
QYResearch

Abstracts

This report studies Self-administered Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Abbott Laboratories
• Bristol-Myers Squibb
• Novartis AG
• Eli Lilly and Company
• Gilead Sciences
• Antares Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Injectable Drugs
• Inhaled Drugs
• Transdermal Drugs

By Application, the market can be split into

• Cardiovascular Diseases
• Diabetes
• Osteoporosis
• Pain Management
• Hormone Replacement
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Self-administered Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF SELF-ADMINISTERED DRUGS

1.1 Definition and Specifications of Self-administered Drugs
  1.1.1 Definition of Self-administered Drugs
  1.1.2 Specifications of Self-administered Drugs
1.2 Classification of Self-administered Drugs
  1.2.1 Injectable Drugs
  1.2.2 Inhaled Drugs
  1.2.3 Transdermal Drugs
1.3 Applications of Self-administered Drugs
  1.3.1 Cardiovascular Diseases
  1.3.2 Diabetes
  1.3.3 Osteoporosis
  1.3.4 Pain Management
  1.3.5 Hormone Replacement
  1.3.6 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF SELF-ADMINISTERED DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Self-administered Drugs
2.3 Manufacturing Process Analysis of Self-administered Drugs
2.4 Industry Chain Structure of Self-administered Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF SELF-ADMINISTERED DRUGS

3.1 Capacity and Commercial Production Date of Global Self-administered Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Self-administered Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Self-administered Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Self-administered Drugs Major Manufacturers in 2016

4 GLOBAL SELF-ADMINISTERED DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Self-administered Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Self-administered Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Self-administered Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Self-administered Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Self-administered Drugs Sales Price
  4.4.2 2016 Self-administered Drugs Sales Price Analysis (Company Segment)

5 SELF-ADMINISTERED DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Self-administered Drugs Market Analysis
  5.1.1 North America Self-administered Drugs Market Overview
  5.1.2 North America 2012-2017E Self-administered Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Self-administered Drugs Sales Price Analysis
  5.1.4 North America 2016 Self-administered Drugs Market Share Analysis
5.2 China Self-administered Drugs Market Analysis
  5.2.1 China Self-administered Drugs Market Overview
  5.2.2 China 2012-2017E Self-administered Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Self-administered Drugs Sales Price Analysis
  5.2.4 China 2016 Self-administered Drugs Market Share Analysis
5.3 Europe Self-administered Drugs Market Analysis
  5.3.1 Europe Self-administered Drugs Market Overview
  5.3.2 Europe 2012-2017E Self-administered Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Self-administered Drugs Sales Price Analysis
  5.3.4 Europe 2016 Self-administered Drugs Market Share Analysis
5.4 Southeast Asia Self-administered Drugs Market Analysis
  5.4.1 Southeast Asia Self-administered Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Self-administered Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Self-administered Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Self-administered Drugs Market Share Analysis
5.5 Japan Self-administered Drugs Market Analysis
  5.5.1 Japan Self-administered Drugs Market Overview
  5.5.2 Japan 2012-2017E Self-administered Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Self-administered Drugs Sales Price Analysis
  5.5.4 Japan 2016 Self-administered Drugs Market Share Analysis
5.6 India Self-administered Drugs Market Analysis
  5.6.1 India Self-administered Drugs Market Overview
  5.6.2 India 2012-2017E Self-administered Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Self-administered Drugs Sales Price Analysis
  5.6.4 India 2016 Self-administered Drugs Market Share Analysis

6 GLOBAL 2012-2017E SELF-ADMINISTERED DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Self-administered Drugs Sales by Type
6.2 Different Types of Self-administered Drugs Product Interview Price Analysis
6.3 Different Types of Self-administered Drugs Product Driving Factors Analysis
  6.3.1 Injectable Drugs of Self-administered Drugs Growth Driving Factor Analysis
  6.3.2 Inhaled Drugs of Self-administered Drugs Growth Driving Factor Analysis
  6.3.3 Transdermal Drugs of Self-administered Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E SELF-ADMINISTERED DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Self-administered Drugs Consumption by Application
7.2 Different Application of Self-administered Drugs Product Interview Price Analysis
7.3 Different Application of Self-administered Drugs Product Driving Factors Analysis
  7.3.1 Cardiovascular Diseases of Self-administered Drugs Growth Driving Factor Analysis
  7.3.2 Diabetes of Self-administered Drugs Growth Driving Factor Analysis
  7.3.3 Osteoporosis of Self-administered Drugs Growth Driving Factor Analysis
  7.3.4 Pain Management of Self-administered Drugs Growth Driving Factor Analysis
  7.3.5 Hormone Replacement of Self-administered Drugs Growth Driving Factor Analysis
  7.3.6 Others of Self-administered Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF SELF-ADMINISTERED DRUGS

8.1 Abbott Laboratories
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Abbott Laboratories 2016 Self-administered Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Abbott Laboratories 2016 Self-administered Drugs Business Region Distribution Analysis
8.2 Bristol-Myers Squibb
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bristol-Myers Squibb 2016 Self-administered Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bristol-Myers Squibb 2016 Self-administered Drugs Business Region Distribution Analysis
8.3 Novartis AG
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Novartis AG 2016 Self-administered Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Novartis AG 2016 Self-administered Drugs Business Region Distribution Analysis
8.4 Eli Lilly and Company
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Eli Lilly and Company 2016 Self-administered Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Eli Lilly and Company 2016 Self-administered Drugs Business Region Distribution Analysis
8.5 Gilead Sciences
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Gilead Sciences 2016 Self-administered Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Gilead Sciences 2016 Self-administered Drugs Business Region Distribution Analysis
8.6 Antares Pharma
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Antares Pharma 2016 Self-administered Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Antares Pharma 2016 Self-administered Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF SELF-ADMINISTERED DRUGS MARKET

9.1 Global Self-administered Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Self-administered Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Self-administered Drugs Sales Price Forecast
9.2 Self-administered Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Self-administered Drugs Consumption Forecast
  9.2.2 China 2017-2022 Self-administered Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Self-administered Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Self-administered Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Self-administered Drugs Consumption Forecast
  9.2.6 India 2017-2022 Self-administered Drugs Consumption Forecast
9.3 Self-administered Drugs Market Trend (Product Type)
9.4 Self-administered Drugs Market Trend (Application)

10 SELF-ADMINISTERED DRUGS MARKETING TYPE ANALYSIS

10.1 Self-administered Drugs Regional Marketing Type Analysis
10.2 Self-administered Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Self-administered Drugs by Region
10.4 Self-administered Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF SELF-ADMINISTERED DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL SELF-ADMINISTERED DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Self-administered Drugs
Table Product Specifications of Self-administered Drugs
Table Classification of Self-administered Drugs
Figure Global Production Market Share of Self-administered Drugs by Type in 2016
Figure Injectable Drugs Picture
Table Major Manufacturers of Injectable Drugs
Figure Inhaled Drugs Picture
Table Major Manufacturers of Inhaled Drugs
Figure Transdermal Drugs Picture
Table Major Manufacturers of Transdermal Drugs
Table Applications of Self-administered Drugs
Figure Global Consumption Volume Market Share of Self-administered Drugs by Application in 2016
Figure Cardiovascular Diseases Examples
Table Major Consumers in Cardiovascular Diseases
Figure Diabetes Examples
Table Major Consumers in Diabetes
Figure Osteoporosis Examples
Table Major Consumers in Osteoporosis
Figure Pain Management Examples
Table Major Consumers in Pain Management
Figure Hormone Replacement Examples
Table Major Consumers in Hormone Replacement
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Self-administered Drugs by Regions
Figure North America Self-administered Drugs Market Size (Million USD) (2012-2022)
Figure China Self-administered Drugs Market Size (Million USD) (2012-2022)
Figure Europe Self-administered Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Self-administered Drugs Market Size (Million USD) (2012-2022)
Figure Japan Self-administered Drugs Market Size (Million USD) (2012-2022)
Figure India Self-administered Drugs Market Size (Million USD) (2012-2022)
Table Self-administered Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Self-administered Drugs in 2016
Figure Manufacturing Process Analysis of Self-administered Drugs
Figure Industry Chain Structure of Self-administered Drugs
Table Capacity and Commercial Production Date of Global Self-administered Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Self-administered Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Self-administered Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Self-administered Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Self-administered Drugs 2012-2017
Figure Global 2012-2017E Self-administered Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Self-administered Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Self-administered Drugs Capacity and Growth Rate
Table 2016 Global Self-administered Drugs Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Self-administered Drugs Sales (K MT) and Growth Rate
Table 2016 Global Self-administered Drugs Sales (K MT) List (Company Segment)
Table 2012-2017E Global Self-administered Drugs Sales Price (USD/MT)
Table 2016 Global Self-administered Drugs Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Self-administered Drugs 2012-2017E
Figure North America 2012-2017E Self-administered Drugs Sales Price (USD/MT)
Figure North America 2016 Self-administered Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Self-administered Drugs 2012-2017E
Figure China 2012-2017E Self-administered Drugs Sales Price (USD/MT)
Figure China 2016 Self-administered Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Self-administered Drugs 2012-2017E
Figure Europe 2012-2017E Self-administered Drugs Sales Price (USD/MT)
Figure Europe 2016 Self-administered Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Self-administered Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Self-administered Drugs Sales Price (USD/MT)
Figure Southeast Asia 2016 Self-administered Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Self-administered Drugs 2012-2017E
Figure Japan 2012-2017E Self-administered Drugs Sales Price (USD/MT)
Figure Japan 2016 Self-administered Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Self-administered Drugs 2012-2017E
Figure India 2012-2017E Self-administered Drugs Sales Price (USD/MT)
Figure India 2016 Self-administered Drugs Sales Market Share
Table Global 2012-2017E Self-administered Drugs Sales (K MT) by Type
Table Different Types Self-administered Drugs Product Interview Price
Table Global 2012-2017E Self-administered Drugs Sales (K MT) by Application
Table Different Application Self-administered Drugs Product Interview Price
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Self-administered Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Abbott Laboratories Self-administered Drugs Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Self-administered Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Bristol-Myers Squibb Self-administered Drugs Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novartis AG Self-administered Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novartis AG Self-administered Drugs Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly and Company Self-administered Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Eli Lilly and Company Self-administered Drugs Business Region Distribution
Table Gilead Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gilead Sciences Self-administered Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Gilead Sciences Self-administered Drugs Business Region Distribution
Table Antares Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Antares Pharma Self-administered Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Antares Pharma Self-administered Drugs Business Region Distribution
Figure Global 2017-2022 Self-administered Drugs Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Self-administered Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Self-administered Drugs Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Self-administered Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Self-administered Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Self-administered Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Self-administered Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Self-administered Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Self-administered Drugs Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Self-administered Drugs by Type 2017-2022
Table Global Consumption Volume (K MT) of Self-administered Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Self-administered Drugs by Region